© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
© 2022 MJH Life Sciences™ and Drug Topics. All rights reserved.
June 13, 2022
Adjunctive metformin in bipolar disorder. Researchers performed a randomized clinical trial of treating insulin resistance to improve clinical outcomes in treatment-resistant bipolar depression.
May 27, 2022
Axsome Therapeutics announced the robust antidepressant efficacy demonstrated in this latest study.
May 25, 2022
Medical staff, pushed past their breaking point, say something has to change.
May 23, 2022
New research presented at the 2022 American Psychiatric Association Annual Meeting evaluated program to help address the opioid epidemic.
May 13, 2022
The approval makes the drug the first novel nonstimulant ADHD therapy approved in the last 20 years.
May 12, 2022
Up to 20% of patients with bipolar disorder have 4 or more medications, so it is important to be aware of these common drug-drug interactions.
May 11, 2022
Home environments have a clear impact on depression treatment outcomes.
May 06, 2022
Pharmacogenetics can inform precision prescribing practices, which in turn can solve the inefficiencies of current prescribing models.
April 27, 2022
A recent study found a negative association between children with ADHD and health eating patterns.
April 21, 2022
The warnings cite consumer risks and Food, Drug and Cosmetics Act violations.